NDC 0169-0081-83 - Prandin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0169-0081
- Requested NDC
- 0169-0081-83
- Package NDCs from labels
- 0169-0081-81, 0169-0081-82, 0169-0081-80, 0169-0081-83
- Manufacturer
- Novo Nordisk | Boehringer Ingelheim Pharma GmbH and Co. KG
- Effective date
- 2019-02-06
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Prandin - Novo Nordisk | Boehringer Ingelheim Pharma GmbH and Co. KG | Novo Nordisk | Boehringer Ingelheim Pharma GmbH and Co. KG | 2019-02-06 | HUMAN PRESCRIPTION DRUG LABEL |
| Prandin - Carilion Materials Management | Carilion Materials Management | 2017-12-28 | HUMAN PRESCRIPTION DRUG LABEL |
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2012-07-24 | Indexing - Billing Unit |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0169-0081-81 | EA - Each | 0169-0081 | b022d1e9-d530-48e8-8a70-179c8b299345 | 1 | 2012-07-24 |
| 0169-0081-83 | EA - Each | 0169-0081 | 979d1a24-27db-4a3a-b9b0-dee6fe0114a6 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| REPAGLINIDE | ACTIVE INGREDIENT | 668Z8C33LU | PRANDIN (REPAGLINIDE) TABLET [NOVO NORDISK] | 8 | |
| REPAGLINIDE | ACTIVE MOIETY | 668Z8C33LU | PRANDIN (REPAGLINIDE) TABLET [NOVO NORDISK] | 8 | |
| REPAGLINIDE | ACTIVE INGREDIENT | 668Z8C33LU | PRANDIN (REPAGLINIDE) TABLET [CARILION MATERIALS MANAGEMENT] | 2 | |
| REPAGLINIDE | ACTIVE MOIETY | 668Z8C33LU | PRANDIN (REPAGLINIDE) TABLET [CARILION MATERIALS MANAGEMENT] | 2 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Repaglinide | REPAGLINIDE | Bryant Ranch Prepack | 6ae28683-28cc-408e-90f9-6a3dddfc668d | 2025-11-04 | Warnings, Adverse reactions | 668Z8C33LU |
| Repaglinide | REPAGLINIDE | NorthStar RxLLC | 7f3118ce-fcbb-4f8b-b1ba-d8cd95e5b665 | 2025-09-15 | Warnings, Adverse reactions | 200257 668Z8C33LU |
| Repaglinide | REPAGLINIDE | Bryant Ranch Prepack | d85abce4-16da-4231-b28a-6afca04ebf68 | 2025-06-05 | Warnings, Adverse reactions | 668Z8C33LU |
| Repaglinide | REPAGLINIDE | Chartwell RX, LLC | cb995e92-295e-4638-a064-978211f5afe1 | 2025-05-02 | Warnings, Adverse reactions | 200257 668Z8C33LU |
| Repaglinide | REPAGLINIDE | Bryant Ranch Prepack | 9f2006d9-e0c0-4cc4-b2c9-84b7d9f77173 | 2025-01-23 | Warnings, Adverse reactions | 200257 668Z8C33LU |
| Repaglinide | REPAGLINIDE | Bryant Ranch Prepack | 3b150917-e2fd-4366-af83-ebc1d7297ca9 | 2025-01-16 | Warnings, Adverse reactions | 200257 668Z8C33LU |
| Repaglinide | REPAGLINIDE | American Health Packaging | dd1d8337-9903-4b8a-a9ea-569e4d134e74 | 2024-10-22 | Warnings, Adverse reactions | 668Z8C33LU |
| Repaglinide | REPAGLINIDE | Aurobindo Pharma Limited | 68064989-47ea-4ed5-a20e-43c4ef6ec271 | 2024-05-14 | Warnings, Adverse reactions | 200257 668Z8C33LU |
| Repaglinide | REPAGLINIDE | Rising Pharma Holdings, Inc. | d7673e22-0dbb-4395-ad60-943d249203a1 | 2024-05-14 | Warnings, Adverse reactions | 200257 668Z8C33LU |
| Repaglinide | REPAGLINIDE | Macleods Pharmaceuticals Limited | 7a93246c-9323-40c4-b590-a40dcb133c8c | 2023-04-04 | Warnings, Adverse reactions | 200257 668Z8C33LU |
| 814078bb-8c13-a996-e053-2991aa0ab042 | 4c1c212f-71a5-4dd3-81b2-cd9e2148774c | 2019-02-06 | Warnings, Adverse reactions | 814078bb-8c13-a996-e053-2991aa0ab042 4c1c212f-71a5-4dd3-81b2-cd9e2148774c | ||
| fa1c312b-dbb4-4ce7-9c13-b34a0f4448d4 | 813f781f-7db8-49ed-b4ed-a829c37eddb7 | 2017-12-28 | Warnings, Adverse reactions | fa1c312b-dbb4-4ce7-9c13-b34a0f4448d4 813f781f-7db8-49ed-b4ed-a829c37eddb7 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.